{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:07:37Z","timestamp":1787501257959,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.7759\/cureus.19202","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T08:14:27Z","timestamp":1635840867000},"source":"Crossref","is-referenced-by-count":4,"title":["Recurrent Erythema Multiforme Induced by the Combination of Pembrolizumab and Radiation"],"prefix":"10.7759","author":[{"given":"Austin B","family":"Ambur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Mammino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Bolognia JL","year":"2018","unstructured":"Bolognia JL, Schaffer JV, Cerroni L. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. Dermatology. Fourth Edition. Elsevier, China; 2018."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000248332","article-title":"Erythema multiforme associated with radiotherapy","volume":"179","author":"Salomon D","year":"1989","unstructured":"Salomon D, Saurat JH. Erythema multiforme associated with radiotherapy. Dermatologica. 1989, 179:110-1. 10.1159\/000248332","journal-title":"Dermatologica"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1673.1996.tb00414.x","article-title":"Erythema multiforme-like reaction associated with radiotherapy","volume":"40","author":"Veness MJ","year":"1996","unstructured":"Veness MJ, Dwyer PK. Erythema multiforme-like reaction associated with radiotherapy. Australas Radiol. 1996, 40:334-7. 10.1111\/j.1440-1673.1996.tb00414.x","journal-title":"Australas Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1989.tb02537.x","article-title":"Radiation-induced erythema multiforme. An unusual presentation with elastic tissue phagocytosis","volume":"28","author":"Pandya AG","year":"1989","unstructured":"Pandya AG, Kettler AH, Bruce S. Radiation-induced erythema multiforme. An unusual presentation with elastic tissue phagocytosis. Int J Dermatol. 1989, 28:600-2. 10.1111\/j.1365-4362.1989.tb02537.x","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.1912","article-title":"Timing of onset of adverse cutaneous reactions associated with programmed cell death protein 1 inhibitor therapy","volume":"154","author":"Wang LL","year":"2018","unstructured":"Wang LL, Patel G, Chiesa-Fuxench ZC, et al.. Timing of onset of adverse cutaneous reactions associated with programmed cell death protein 1 inhibitor therapy. JAMA Dermatol. 2018, 154:1057-61. 10.1001\/jamadermatol.2018.1912","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13060","article-title":"In-vitro effect of pembrolizumab on different T regulatory cell subsets","volume":"191","author":"Toor SM","year":"2018","unstructured":"Toor SM, Syed Khaja AS, Alkurd I, Elkord E. In-vitro effect of pembrolizumab on different T regulatory cell subsets. Clin Exp Immunol. 2018, 191:189-97. 10.1111\/cei.13060","journal-title":"Clin Exp Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000485910","article-title":"A case of erythema multiforme major developed after sequential use of two immune checkpoint inhibitors, nivolumab and ipilimumab, for advanced melanoma: possible implication of synergistic and\/or complementary immunomodulatory effects","volume":"10","author":"Utsunomiya A","year":"2018","unstructured":"Utsunomiya A, Oyama N, Iino S, Baba N, Chino T, Utsunomiya N, Hasegawa M. A case of erythema multiforme major developed after sequential use of two immune checkpoint inhibitors, nivolumab and ipilimumab, for advanced melanoma: possible implication of synergistic and\/or complementary immunomodulatory effects. Case Rep Dermatol. 2018, 10:1-6. 10.1159\/000485910","journal-title":"Case Rep Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2016.09.011","article-title":"Inflammatory skin conditions associated with radiotherapy","volume":"108","author":"Hern\u00e1ndez Arag\u00fc\u00e9s I","year":"2017","unstructured":"Hern\u00e1ndez Arag\u00fc\u00e9s I, Pulido P\u00e9rez A, Su\u00e1rez Fern\u00e1ndez R. Inflammatory skin conditions associated with radiotherapy. Actas Dermosifiliogr. 2017, 108:209-20. 10.1016\/j.ad.2016.09.011","journal-title":"Actas Dermosifiliogr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/70914-recurrent-erythema-multiforme-induced-by-the-combination-of-pembrolizumab-and-radiation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:35:55Z","timestamp":1707489355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/70914-recurrent-erythema-multiforme-induced-by-the-combination-of-pembrolizumab-and-radiation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.19202","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,2]]}}}